Evidence map›Paper›PMID 41465478›Full record

ArticleInternational journal of molecular sciences2025

Therapeutic Potential of

Nora Tawfeek, Raha Orfali, Shagufta Perveen, Safina Ghafar, Eman Fikry, Mahmoud H Elbatreek, Samar S Elbaramawi, Maher M El-Domiaty, Azza M El-Shafae

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nora TawfeekDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Raha OrfaliDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Shagufta PerveenDepartment of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.ORCID 0000-0002-3318-9861
Safina GhafarDepartment of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
Eman FikryDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0002-4434-2075
Mahmoud H ElbatreekDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0003-2437-1773
Samar S ElbaramawiDepartment of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-8658-1296
Maher M El-DomiatyDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
Azza M El-ShafaeDepartment of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.ORCID 0000-0001-8574-9608

Funding

King Saud University ORF-2025-431
6 · The paper itself

Abstract

Ulcerative colitis represents a chronic inflammatory bowel disease with limited therapeutic options due to inadequate efficacy and adverse effects of current treatments. This study investigated the therapeutic potential of

Indexed as

Colitis, UlcerativePhytochemicalsPlant ExtractsPlant LeavesAnimalsCytokinesDisease Models, AnimalMaleMolecular Docking SimulationNetwork PharmacologyOxidative StressRatsRats, Sprague-DawleyCytokinesPhytochemicalsPlant Extractsanti-inflammatoryBeaucarnea recurvatainflammatory bowel diseasenetwork pharmacologysteroidal saponinsulcerative colitis

Identifiers

PMID41465478
PMCPMC12733345

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.